Journal of Pediatric Orthopaedics - 2026-01-01 - Journal Article
The Age of Definitive Fusion Surgery for Early Onset Scoliosis Has Remained Constant Over the Past 2 Decades.
Abid R, Murphy RF, Hogue GD, Akbarnia BA, Smith JT, Hardesty CK, Pediatric Spine Study Group
Topics
Key Takeaway
Over 17 years, age at definitive fusion for EOS remained unchanged overall (mean 12.1 years), with significant increases only in congenital EOS (10.6→12.3 years) and females (11.4→12.1 years).
Summary Depth
Choose how much analysis to show on this article page.
Summary
This study asked whether the clinical trend toward delaying definitive spinal fusion in EOS has translated into measurable changes in patient age at fusion over 17 years at a single institution. Multiple linear regression on 791 patients fused at age ≤5 years onset (2005–2022) found no significant change in fusion age for the overall cohort or for idiopathic, syndromic, or neuromuscular subtypes. Congenital EOS patients showed a significant age increase (coefficient 0.171, P=0.006, predicted 10.6→12.3 years) and females showed a modest but significant increase (coefficient 0.082, P=0.003, predicted 11.4→12.1 years).
Key Limitation
Single-institution design precludes determining whether the absence of a temporal trend reflects true national practice or local institutional inertia, and the study cannot distinguish cases where fusion followed a planned growth-modulation phase from primary early fusion.
Original Abstract
BACKGROUND
Treatment options for early-onset scoliosis (EOS) are confounded by the risks associated with intervention at a younger age. Spinal instrumentation must be considered carefully due to potentially adverse effects to the spine, chest wall, and lungs. Posterior spinal fusion before subsequent growth can also lead to the crankshaft phenomenon. With the recent increasing interest in delaying spinal fusion, we aim to determine trends in patient age selection at a single definitive (termed "one and done") fusion for EOS.
METHODS
We identified 791 patients from 2005 to 2022 who met the inclusion criteria (age 5 y or younger, single definitive fusion, and complete data). Patients who underwent a hemivertebrae resection with limited fusion were not included. Multiple linear regression was performed with date of fusion as the independent variable and age at definitive fusion as the dependent variable. Our regression included race and sex to control for their effects as confounders. We repeated this analysis with groups separated by scoliosis etiology and sex. Coefficients with P <0.05 were considered significant.
RESULTS
In the entire cohort, there was no significant change in the age at definitive fusion between 2005 and 2022 (coefficient=0.042, P =0.099). The mean age at fusion was 12.1 years. Of these, 167 (21.1%) cases had congenital scoliosis, 277 (35.0%) had idiopathic scoliosis, 191 (24.1%) had neuromuscular scoliosis, and 156 (19.7%) had syndromic scoliosis. Patients with idiopathic (-0.002, P =0.962), syndromic (-0.027, P =0.671), and neuromuscular (-0.005, P =0.924) EOS showed no significant change in the age at fusion. However, children with congenital EOS (0.171, P =0.006) and females (0.082, P =0.003) demonstrated a significant increase. On the basis of our regression models, the predicted age at definitive fusion increased from 10.6 years to 12.3 years in those with congenital EOS and from 11.4 to 12.1 years in females.
CONCLUSIONS
Over a 17-year study period, females and congenital EOS patients demonstrated significant increases in age at the time of definite fusion. There was no significant change for children with neuromuscular, idiopathic, or syndromic EOS over the same time frame. Further study is necessary to determine the nature of these disparities.